NCT00905047 2026-03-13
COLOCROSS
Centre Oscar Lambret
Phase 3 Completed
Clinical Trials
58 trialsNCT05171660 2026-02-17
Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Active not recruiting
NCT04854668 2026-01-30
A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Active not recruiting
NCT07340567 2026-01-14
CIRCULATEIII
UNICANCER
Phase 3 Not yet recruiting
NCT03869892 2025-12-22
SOLSTICE
Servier
Phase 3 Active not recruiting
NCT04607421 2025-08-14
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
Phase 3 Active not recruiting
NCT03828227 2025-07-18
COLAGE
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Active not recruiting
NCT07025239 2025-06-17
QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT02934529 2025-04-16
AIO-KRK-0114
Ludwig-Maximilians - University of Munich
Phase 3 Completed
NCT01167725 2024-12-27
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT04456699 2024-10-29
LYNK-003
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00958737 2023-09-29
IDEA
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Unknown
NCT04262635 2023-08-02
C-CLASSIC
Sun Yat-sen University
Phase 3 Unknown
NCT03950154 2023-08-01
Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT00202774 2023-04-12
Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Phase 3 Completed
NCT01718873 2023-04-12
OBELICS
National Cancer Institute, Naples
Phase 3 Completed
NCT05797077 2023-04-04
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Recruiting
NCT05699746 2023-01-26
CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD
Zhejiang University
Phase 3 Not yet recruiting
NCT05236972 2022-12-30
PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
Sun Yat-sen University
Phase 3 Recruiting
NCT02121405 2022-05-11
PSSR
Zhejiang University
Phase 3 Suspended
NCT00070213 2021-09-27
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Medical Research Council
Phase 3 Completed
NCT00227747 2021-02-17
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
UNICANCER
Phase 3 Completed
NCT01224392 2020-12-30
RectumSIB
Universitair Ziekenhuis Brussel
Phase 3 Completed
NCT03300609 2020-06-11
5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab
University of Southern California
Phase 3 Terminated
NCT00069121 2020-03-06
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT03448549 2020-03-06
SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
Peking University Cancer Hospital & Institute
Phase 3 Unknown
NCT02251977 2019-10-07
Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer
Sun Yat-sen University
Phase 3 Completed
NCT01996306 2019-01-08
AXEPT
Epidemiological and Clinical Research Information Network
Phase 3 Completed
NCT00749450 2018-07-27
Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
Cancer Research UK, Glasgow
Phase 3 Completed
NCT01918852 2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3 Completed
NCT01279681 2017-12-08
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT01308086 2017-08-09
Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
Hellenic Oncology Research Group
Phase 3 Unknown
NCT02060669 2017-04-27
Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
Samsung Medical Center
Phase 3 Terminated
NCT00399035 2016-12-28
HORIZON II
AstraZeneca
Phase 3 Completed
NCT00766155 2016-10-12
PETACC-6
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00069095 2016-10-06
A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT02316535 2016-09-13
LcACEC
West China Hospital
Phase 3 Unknown
NCT00009737 2016-06-22
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT00058474 2016-03-23
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer
NSABP Foundation Inc
Phase 3 Unknown
NCT00973609 2015-09-01
Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)
AIO-Studien-gGmbH
Phase 3 Completed
NCT00396487 2015-06-11
Tailored Treatment in Metastatic Colorectal Cancer
Vejle Hospital
Phase 3 Terminated
NCT01229813 2015-04-13
ACT2
Lund University Hospital
Phase 3 Completed
NCT00484939 2015-01-08
A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT00623805 2014-08-08
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT00442637 2013-12-12
CAIRO3
Dutch Colorectal Cancer Group
Phase 3 Unknown
NCT00062426 2013-11-06
Oxaliplatin and Bevacizumab (Avastinâ„¢) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00427713 2013-08-26
Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01097018 2013-07-02
X-PECT
AEterna Zentaris
Phase 3 Completed
NCT00677443 2013-06-14
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Samsung Medical Center
Phase 3 Completed
NCT00268463 2013-05-15
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
NSABP Foundation Inc
Phase 3 Terminated